Searched for
MANKIND PHARMA BLOCK DEAL SIZE
PB Fintech shares slide up to 8% after Temasek arm likely sells over 2% stake via block dealPB Fintech shares fell sharply on Friday after reports said Temasek-linked MacRitchie Investments likely sold more than a 2% stake via a bl...- Cred’s angels, institutional investors score big in Meta dealThe sale is part of Meta’s $900 million investment in Cred, which valued the Kunal Shah-founded company at about $4 billion. The transactio...
- Adani Enterprises increases QIP size to Rs 15,000 crore, draws bumper 3.8x bidsAdani Enterprises successfully upsized its qualified institutional placement to Rs 15,000 crore, attracting bids worth Rs 38,000 crore due ...
- Mynd Fintech, part of Treds platform M1xchange, acquires C2FO IndiaM1xchange is an RBI-licensed Treds (Trade Receivables Electronic Discounting System) entity. C2FO runs C2Treds and also has the same licenc...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- US Independence Day: As America gears up for its 250th Independence Day, check Fourth of July grocery deals and discountsAs America gears up for its 250th Independence Day, major retailers are rolling out significant Fourth of July deals. Expect substantial sa...
- Battery recycler BatX Energies raises Rs 105 crore from IvyCap Ventures, othersBatX Energies has secured Rs 105 crore in a funding round led by IvyCap Ventures, with participation from existing investors. The startup s...
- Mankind Pharma partners Denovo Sciences for AI-led drug discoveryMankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to si...
- Paramount moves to ease EU antitrust concerns over Warner Bros Discovery dealParamount Skydance Corp has offered solutions to EU competition watchdogs regarding its massive Warner Bros Discovery acquisition. The comp...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- IT growth vectors "clearly missing"; EV capex pullback hits ER&D players: Mayuresh JoshiIndia's IT and ER&D sectors are navigating a structural slowdown, with EV capex cuts impacting companies like KPIT. Near-term macro risks, ...
- Fourth of July restaurant deals 2026: Where to get free doughnuts, $2.50 burgers, 99-cent corn dogs and more this Independence DayCelebrate the Fourth of July without breaking the bank! Restaurants nationwide are offering incredible deals, from 99-cent corn dogs and $2...
- UK may intervene in $110 billion Paramount-Warner Bros Discovery dealBritain is considering intervening in Paramount's proposed $110 billion takeover of Warner Bros Discovery, potentially delaying the deal de...
- Institutional demand sparks surge in block deals as promoters book profitsPromoters and large shareholders are cashing in on a stock market rebound, offloading shares worth over ₹24,000 crore in May and June. This...
- Greece's iconic Parthenon is back: One of the world’s most famous temples just reclaimed a lost piece of historyGreece Parthenon restoration: Athens' iconic Parthenon has regained a significant piece of its history with the completion of its western p...
- Fidelity Investments buys 2 pc stake in Lodha Developers for Rs 1,864 croreFidelity Investments has strategically acquired a 2% stake in Lodha Developers, amounting to Rs 1,864 crore, through open market operations...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Block deal alert! Craftsman Auto shares in focus as promoter to sell stake worth Rs 486 croreCraftsman Automation shares are under scrutiny as promoter Srinivasan Ravi plans to sell up to 2.01% stake via a block deal worth Rs 486 cr...
Load More
